What is insider trading data?

Insider trading data comes from SEC Form 4 filings, which corporate insiders must file within 2 business days of buying or selling company stock. This includes CEOs, CFOs, directors, and major shareholders.

How do I track congressional stock trades?

InsiderStreet.ai aggregates financial disclosures from the STOCK Act, showing stock trades by members of Congress. These are typically disclosed within 45 days of the transaction.

What are 13F filings?

13F filings are quarterly reports that institutional investment managers with over $100 million in assets must file with the SEC, revealing their equity holdings.

Financial News — InsiderStreet

AdaptHealth (NASDAQ:AHCO) Trading Up 8.3% on Insider Buying Activity

AdaptHealth Corp. (NASDAQ:AHCO – Get Free Report)’s stock price was up 8.3% during trading on Tuesday following insider buying activity....

bullish AHCO DefenseWorld 1d ago

Monopar Therapeutics Inc. (NASDAQ:MNPR) Receives Consensus Rating of “Buy” from Analysts

Monopar Therapeutics Inc. (NASDAQ:MNPR – Get Free Report) has been given a consensus rating of “Buy” by the thirteen analysts that...

bullish MNPR DefenseWorld 1d ago

GeneDx Holdings Corp. (NASDAQ:WGS) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of GeneDx Holdings Corp. (NASDAQ:WGS – Get Free Report) have been given a consensus rating of “Moderate Buy” by the nine...

bullish WGSWW DefenseWorld 1d ago

Arcus Biosciences, Inc. (NYSE:RCUS) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Arcus Biosciences, Inc. (NYSE:RCUS – Get Free Report) have been given a consensus rating of “Moderate Buy” by the twelve...

bullish RCUS DefenseWorld 1d ago

Adagio Medical (NASDAQ:ADGM) Trading Up 11.5% – Time to Buy?

Adagio Medical Holdings, Inc. (NASDAQ:ADGM – Get Free Report)’s share price traded up 11.5% during mid-day trading on Tuesday . The stock...

bullish ADGM DefenseWorld 1d ago

📰

Novo Nordisk A/S: Triple agonist UBT251 showed a mean HbA1c reduction of up to 2.16% after 24 weeks in phase 2 trial in Chinese patients with type 2 diabetes

UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G), being jointly developed by United Biotechnology and Novo...

bullish ULIHF Yahoo Finance 1d ago

📰

Apogee Therapeutics prices upsized $350M offering at $70 a share

bullish APGE SeekingAlpha 1d ago

Achieve Life Sciences Sees Unusually Large Options Volume (NASDAQ:ACHV)

Achieve Life Sciences, Inc. (NASDAQ:ACHV – Get Free Report) was the target of unusually large options trading activity on Tuesday. Stock...

bullish ACHV DefenseWorld 1d ago

Palantir And Palmer Luckey's Anduril Team Up On Trump's $185 Billion Golden Dome Missile Shield: Report

Anduril Industries and Palantir Technologies (NASDAQ:PLTR) are reportedly collaborating on software for Donald Trump's ambitious $185 billion...

bullish TECH Benzinga-News 1d ago

📰

Merck close to $6B acquisition of Terns Pharma to boost cancer portfolio: FT

bullish MRK SeekingAlpha 1d ago

📰

Merck close to $6B acquisition of Terns Pharma to boost cancer portfolio: FT

bullish TERN SeekingAlpha 1d ago

Blaize Holdings Is Trending As Stock Shoots Up 49% Overnight: Here's Why

Blaize Holdings Inc. (NASDAQ:BZAI) shares are trending on Tuesday night. Shares of the California-based AI platform company rose 48.65% after hours...

bullish TECH Benzinga-News 1d ago

GIGABYTE AORUS geht eine Partnerschaft mit VALORANT Esports EMEA ein

GIGABYTE AORUS wird die VALORANT Champions Tour EMEA und die Game Changers EMEA in den Spielzeiten 2026 und 2027 als Sponsor unterstützen. Das...

bullish CON PRNewswire 1d ago

📰

Apogee Therapeutics, Inc. Announces Pricing of $350 Million Underwritten Public Offering

SAN FRANCISCO and BOSTON, March 24, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (NASDAQ:APGE), a clinical-stage biotechnology company...

bullish APGE Benzinga-News 1d ago

📰

Absci outlines $25B annual market potential for ABS-201 in AGA and advances endometriosis clinical program

bullish ABSI SeekingAlpha 1d ago

📰

BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit

bullish BCDA SeekingAlpha 1d ago

📰

A Bausch + Lomb Director Just Bought $77,000 in Stock. That's Only Half the Story

Bausch + Lomb, a global leader in eye health products and surgical devices, reported a recent insider buy amid ongoing sector activity.

bullish BLCO MotleyFool 1d ago

📰

Tela Bio targets at least 8% revenue growth in 2026 while advancing commercial transformation

bullish TELA SeekingAlpha 1d ago

📰

Fractyl Health outlines 2026 De Novo submission plans with pivotal Revita data expected in early Q4

bullish GUTS SeekingAlpha 1d ago

📰

CVS Health (CVS) Ascends While Market Falls: Some Facts to Note

CVS Health (CVS) concluded the recent trading session at $72.8, signifying a +2.12% move from its prior day's close.

bullish CVS Zacks 1d ago

📰

Grifols approves IPO of its US biopharma business

March 24 (Reuters) - Spanish drugmaker Grifols said on Tuesday it has approved a U.S. initial public offering of its U.S. biopharma business.

bullish GIKLY Yahoo Finance 1d ago

📰

Grifols considers IPO of part of its US biopharma business

bullish GRFS SeekingAlpha 1d ago

Dynamic Advisor Solutions LLC Has $2.85 Million Stake in Thermo Fisher Scientific Inc. $TMO

Dynamic Advisor Solutions LLC reduced its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 18.4% in the 4th...

bullish TMO DefenseWorld 1d ago

Central Bank & Trust Co. Trims Position in UnitedHealth Group Incorporated $UNH

Central Bank & Trust Co. reduced its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 27.1% in the 4th quarter,...

bullish UNH.BA DefenseWorld 1d ago